glp-1 week 1 First on Semaglutide GLP-1: How Your Body May Respond GLP-1 Journey: Week One |

A Differentiated Next-Generation GLP Candidate SureNano Science is advancing GEP-44 as a patented, next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs, positioning this emerging microcap as a minnow among giants quickly transitioning through the FDA pathway

For example, infrared light therapy improved pain and feeling in up to 66% of patients

Want to feel fuller for longer without relying solely on medication

21NT and BT474 were treated with 0.5 and 1 g /ml of epitalon for 4 days, RNA extracted and hTERT mRNA expression levels were quantified using qPCR